Colchicine

Wilmington, Delaware, United States, July 28, 2023 (GLOBE NEWSWIRE) -- The global gout therapeutics market stood at US$ 2.2 billion in 2021 and the global market is projected to reach US$…

The anti-inflammatory colchicine, recently approved for cardiovascular…

MONTRÉAL, 23 juin 2023 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) salue l’approbation par la Food and Drug Administration (FDA) des États-Unis de la colchicine pour…

MONTREAL, June 23, 2023 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for…

However, today's recommendations against their use reflect ongoing uncertainty about how the drugs produce an effect in the body, and evidence of little or no effect on survival and other…

Colchicine (Colcrys) didn't benefit patients hospitalized with moderate to severe…

Adding colchicine (Colcrys) to current standard of care COVID treatment was not associated with…

In a bid to clarify its safety and effectiveness, researchers searched databases looking for relevant comparative clinical trial data on the use of the drug for the treatment of COVID-19…

Treatment with the anti-inflammatory drug colchicine resolved recurrent type 2 autoimmune…

MONTREAL, Aug. 27, 2021 (GLOBE NEWSWIRE) -- People with coronary disease now have a new treatment option to reduce the risk of cardiovascular events. Health Canada has issued a Notice of…